Rahul Chaudhary, Amteshwar Singh, Rohit Chaudhary, Michael Bashline, Damon E Houghton, Alejandro Rabinstein, Jill Adamski, Richard Arndt, Narith N Ou, Maria I Rudis, Caitlin S Brown, Erin D Wieruszewski, Matthew Wanek, Nathan J Brinkman, Jane A Linderbaum, Melissa A Sorenson, John L Atkinson, Kristine M Thompson, Aryan N Aiyer, Robert D McBane
IMPORTANCE: Direct oral anticoagulant (DOAC)-associated intracranial hemorrhage (ICH) has high morbidity and mortality. The safety and outcome data of DOAC reversal agents in ICH are limited. OBJECTIVE: To evaluate the safety and outcomes of DOAC reversal agents among patients with ICH. DATA SOURCES: PubMed, MEDLINE, The Cochrane Library, Embase, EBSCO, Web of Science, and CINAHL databases were searched from inception through April 29, 2022...
November 1, 2022: JAMA Network Open